Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PIONEER

Financiado

Cerrado

Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Dat...

Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope Prostate Cancer (PCa) is the second leading cause of cancer, among men in Europe. There are currently major unmet needs in this field, such as insufficient knowledge on risk factors that contribute to PCa and on patient characteri... ver más

31/10/2023

EAU

14M€

Presupuesto del proyecto: 14M€

Líder del proyecto

STICHTING EUROPEAN UROLOGICAL FOUNDATION No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 39 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-10-31

IMI2-2016-10-02: How Big Data could support better d...

I+D

Cerrada hace 7 años

0% 44% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

39 Participantes

EAU

797.44K€ | Lider

ALTIA CONSULTORES

UNISR

312.50K€ | Participante

TUD

125.00K€ | Participante

Proyectos interesantes

BARCODE

Medical Technol...

Data Science

2M€ Cerrado

EXACTA

Medical Technol...

Data Science

2M€ Cerrado

RYC2021-034415-I

Medical Technol...

Data Science

236K€ Cerrado

PRE2020-092987

Medical Technol...

Data Science

99K€ Cerrado

PCMPS

Medical Technol...

Data Science

71K€ Cerrado

PredAlgoBC

Medical Technol...

Data Science

185K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 64 meses Fecha Inicio: 2018-06-14
Fecha Fin: 2023-10-31

Líder del proyecto

STICHTING EUROPEAN UROLOGICAL FOUNDATION No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 14M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Prostate Cancer (PCa) is the second leading cause of cancer, among men in Europe. There are currently major unmet needs in this field, such as insufficient knowledge on risk factors that contribute to PCa and on patient characteristics (including genetic profiles) that could facilitate patient stratification. Finally, there is lack of meaningful engagement of all key stakeholders, while the knowledge currently gained from clinical practice and real life data is not being fed back into PCa patients’ care pathways. There is thus a need for better definition of PCa across all stages, improved patient’s stratification at diagnosis, and standardisation of PCa-related outcomes based on real life data. PIONEER’s unique dual approach is to first identify critical evidence gaps in PCa by respected Key Opinion Leaders, and then embark on a research priority setting exercise that reflects the needs of all key stakeholders in PCa management. To achieve this, PIONEER has brought together comprehensive datasets that consists of the most relevant prostate clinical trials and registries, large epidemiological cohorts, electronic heath records, and real-life data from different European (and non-European) patient populations. These unique data sets will be integrated, standardised, harmonised and analysed using approaches that are built on our experience of similar previous IMI projects i.e EMIF, and eTRIKS, and analysed using a unique set of methodologies and advanced analytics methods (OMOP, eHS). PIONEER has already performed a first PCa research priority setting survey, where major stakeholders were asked to identify the current unmet needs in PCa. The five most important open questions will be used as pilot studies to verify PIONEER’s research framework. As such, PIONEER’s deliverables will be outcome-driven, value-based and patient-centric, and relevant to all key stakeholders, as they would have been meaningfully involved from the inception of the project.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores